| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
-
May 25, 2022Virtual Press Office and PR Newswire: General Trade show news
Credit Suisse HALO Investment Summit, May 25th B. Riley Securities 22nd Annual Institutional Investor Conference, May 26th BOCA RATON, Fla., May 25, 2022 /PRNewswire/ -- Celsius Holdings, Inc.,...
-
May 25, 2022Virtual Press Office and PR Newswire: General Trade show news
Kasper Roet, Ph.D., founder and CEO, discusses new insights into human genetics and stem cell technology to provide genetically validated targets for sporadic ALS patient populations Angela Genge,...
-
May 25, 2022Virtual Press Office and PR Newswire: General Trade show news
Realogy Holdings Corp. (NYSE: RLGY), the leading and most integrated provider of U.S. residential real estate services, today announced that Chief Executive Officer and President Ryan Schneider...
-
May 25, 2022Virtual Press Office and PR Newswire: General Trade show news
Life Time Group Holdings, Inc. ("Life Time" or the "Company") (NYSE: LTH) today announced that it is scheduled to participate in the 2022 RBC Capital Markets Global Consumer & Retail Conference on...
-
May 25, 2022Virtual Press Office and PR Newswire: General Trade show news
Seoul booth be operated from May 29 to June 2 Joint marketing programs with Seoul MICE Alliance (SMA) Signal of Seoul's preemptive international marketing to boost the recovery of the MICE...
-
May 24, 2022SIGGRAPH
Electronic Theater to Feature 25 Selections, Including 2 World Premiere Shorts CHICAGO , May 24, 2022 /PRNewswire/ -- SIGGRAPH 2022 announces the award winners and lineup of 25 short films,...
-
May 24, 2022Virtual Press Office and PR Newswire: General Trade show news
Myeloid Therapeutics, Inc. ("Myeloid"), a clinical stage mRNA-immunotherapy company developing novel therapies for cancer and autoimmune diseases, today announced that it will participate in the...
-
May 24, 2022Virtual Press Office and PR Newswire: General Trade show news
New data show proportions of patients treated with TREMFYA who achieved clinical-biomarker response ranged from 47.5-66.7 percent across dose groups in the Phase 2 GALAXI 1 study Other data...
-
May 24, 2022Virtual Press Office and PR Newswire: General Trade show news
Three poster presentations continue to highlight the safety and efficacy of IBSRELA based on data from two Phase 3 trials in adults with irritable bowel syndrome with constipation (IBS-C) WALTHAM,...
-
May 24, 2022Virtual Press Office and PR Newswire: General Trade show news
Pasternack, an Infinite Electronics brand and a leading provider of RF, microwave, and millimeter wave products, announced today it will exhibit at the annual IEEE MTT-S International Microwave...
